Urge Urinary Incontinence Clinical Trial
Official title:
Is the a Difference Between Rehabilitation Treatment, Pelvic Floor Muscle Training, Bladder Training and Anticholinergic Drug Treatment in UUI in the Long Term: A Study of Impairment, Quality of Life, and Cost Effectiveness
- Urinary Urge Incontinence (UUI) is the involuntary urine loss associated with a strong
sensation to void.
- UUI usually associated with reduced bladder capacity.
- The pathophysiology is unclear.
- Pelvic floor muscle dysfunction and detrusor instability have been suggested as
possible mechanisms.
- Standard treatment includes anticholinergic medication and behavior modification.
- The study aims to compare the long term effectiveness of 4 different approaches to the
treatment of women with Urge Urinary Incontinence (UUI):
1. Pelvic Floor Rehabilitation (includes muscle training+behavioral
intervention+bladder training)
2. Pelvic Floor muscle training alone
3. Bladder Training alone
4. Drug treatment with Tolterodine.
- Study variables will include: impairment ratings, quality of life, and
cost-effectiveness.
- This study addresses three issues:
1. The long term efficacy and cost-effectiveness of the various treatment options.
2. To identify the factors involved in determining the effectiveness of drug or
behavioral therapy.
3. The pathophysiology of UUI. By subdividing the rehabilitation group into 3 arms,
we hope to shed light on the mechanism of dysfunction. A better response in one
group will help localize the problem to pelvic floor muscles or to detrusor
instability.
The study has 3 phases: Before treatment (phase I), immediately after 3 months of treatment
(phase II), and 1 year post-entry (phase III)
Women with UUI will be divided randomly into one of the four treatment groups. Every subject
will participate in 4 visits. The drug group treatment consists of administration of
tolterodine SR 4 mg daily for 3 months. Subjects who assigned to the pelvic floor
rehabilitation, pelvic floor muscle training, and bladder training groups will be treated
via 4 visits to a physical therapist, who is trained in the procedures. The chief researcher
(RK) will be blinded to the treatment groups and will perform the outcome measures in all
phases.
Study variables will include impairment ratings, quality of life, and cost-effectiveness
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01786967 -
Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)
|
Phase 3 | |
Enrolling by invitation |
NCT01940367 -
Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments
|
N/A | |
Recruiting |
NCT00437528 -
Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity
|
Phase 1 | |
Completed |
NCT04525105 -
SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE
|
||
Terminated |
NCT02129816 -
Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
|
Phase 2/Phase 3 | |
Terminated |
NCT01366066 -
Transcutaneous Mechanical Nerve Stimulation in the Treatment of Incontinence
|
Phase 3 | |
Completed |
NCT01559389 -
Incontinence & Intimate Partners: Assessing the Contribution of Treatment
|
Phase 4 | |
Completed |
NCT01166438 -
Anticholinergic vs. Botox Comparison Study
|
Phase 3 | |
Completed |
NCT00909181 -
Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
|
Phase 3 | |
Terminated |
NCT03923348 -
Pelvic Floor Muscle Training With Leva System for Urge Incontinence
|
N/A | |
Completed |
NCT01445834 -
Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence
|
N/A | |
Terminated |
NCT00373789 -
Refractory Urge Incontinence and Botox Injections
|
Phase 3 | |
Recruiting |
NCT01737411 -
Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women
|
Phase 1/Phase 2 | |
Recruiting |
NCT00770406 -
Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence
|
Phase 1/Phase 2 | |
Completed |
NCT00862745 -
Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES)
|
Phase 4 | |
Completed |
NCT00177541 -
Further Enhancing Non-pharmacologic Therapy for Incontinence
|
N/A | |
Completed |
NCT02311634 -
A Comparison of Electrical Pudendal Nerve Stimulation and Transvaginal Electrical Stimulation for Urge Incontinence
|
N/A | |
Completed |
NCT01672190 -
Lessening Incontinence by Learning Yoga
|
N/A | |
Completed |
NCT01619995 -
Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder
|
N/A |